Latest Insights on Medication Safety & Occupational Health

Over recent years, a class of medicines known as GLP-1 receptor agonists has reshaped approaches to weight management. Medications such as semaglutide (including Wegovy® and Ozempic®) and tirzepatide (e.g. Mounjaro®) were originally developed for the treatment of type 2 diabetes but are now increasingly used to support weight loss in adults with obesity or weight-related health conditions. As their use becomes more widespread among working-age populations, these treatments in